AbbVie raises full-year profit forecast as Humira fuels sales beat – Reuters

AbbVie raises full-year profit forecast as Humira fuels sales beat – Reuters

AbbVie Inc (ABBV.N) beat Wall Street estimates for first-quarter revenue on Friday and raised its full-year profit forecast, helped by demand for blockbuster rheumatoid arthritis drug Humira and newer treatments such as psoriasis treatment Skyrizi.

Read More…

You May Also Like